{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:28:13Z","timestamp":1794475693198,"version":"4.9.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pcad.2024.01.017","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:46:24Z","timestamp":1705794384000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["The spectrum of post-myocardial infarction care: From acute ischemia to heart failure"],"prefix":"10.1016","volume":"82","author":[{"given":"Khawaja Hassan","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Zieroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Estep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"7","key":"10.1016\/j.pcad.2024.01.017_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/clc.20922","article-title":"Heart failure after myocardial infarction: clinical implications and treatment","volume":"34","author":"Minicucci","year":"2011","journal-title":"Clin Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2024.01.017_bb0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s11886-022-01766-6","article-title":"Ischemic cardiomyopathy and heart failure after acute myocardial infarction","volume":"24","author":"Del Buono","year":"2022","journal-title":"Curr Cardiol Rep"},{"issue":"27","key":"10.1016\/j.pcad.2024.01.017_bb0025","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiol.2451061219","article-title":"Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging","volume":"245","author":"Lund","year":"2007","journal-title":"Radiology"},{"issue":"14","key":"10.1016\/j.pcad.2024.01.017_bb0035","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0040","article-title":"Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction","volume":"25","author":"P C, Tf C, K H, Rj G, Ja R","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2024.01.017_bb0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.pcad.2024.01.017_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00395-006-0615-2","article-title":"The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion","volume":"101","author":"Reffelmann","year":"2006","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvn280","article-title":"Mitochondrial oxidative stress and dysfunction in myocardial remodelling","volume":"81","author":"Tsutsui","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.pcad.2024.01.017_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2024.01.017_bb0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00506-7","article-title":"Myocardial stunning and hibernation revisited","volume":"18","author":"Heusch","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015502","article-title":"Stunned and hibernating myocardium: where are we nearly 4 decades later?","volume":"9","author":"Kloner","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2024.01.017_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fcvm.2018.00178","article-title":"C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of ejection fraction","volume":"5","author":"van Wezenbeek","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.pcad.2024.01.017_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2019.08.014","article-title":"Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era","volume":"8","author":"van der Bijl","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.pcad.2024.01.017_bb0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jacc.2020.05.084","article-title":"Spontaneous coronary artery dissection: JACC state-of-the-art review","volume":"76","author":"Hayes","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.pcad.2024.01.017_bb0105","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"issue":"6 Pt 1","key":"10.1016\/j.pcad.2024.01.017_bb0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0002-8703(99)70080-3","article-title":"Clinical predictors of heart failure in patients with first acute myocardial infarction","volume":"138","author":"Ali","year":"1999","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the global registry of acute coronary events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pcad.2024.01.017_bb0120","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.CIR.0000017861.00991.2F","article-title":"Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the national registry of myocardial infarction","volume":"105","author":"Spencer","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/CIRCULATIONAHA.110.964999","article-title":"Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006)","volume":"123","author":"Dudas","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002667","article-title":"Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation-wide analysis including 86 771 patients from the cardiovascular disease in Norway (CVDNOR) project","volume":"5","author":"Sulo","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jchf.2013.02.007","article-title":"Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes","volume":"1","author":"Bahit","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1139\/y05-003","article-title":"Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes","volume":"83","author":"Mehta","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurheartj\/ehn062","article-title":"Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and\/or left ventricular dysfunction: a VALIANT study","volume":"29","author":"Lewis","year":"2008","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.pcad.2024.01.017_bb0155","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0735-1097(03)01057-X","article-title":"Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study","volume":"42","author":"Lewis","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2018.03.005","article-title":"Myocardial infarction data acquisition system (MIDAS 31) study group. Risk factors and trends in incidence of heart failure following acute myocardial infarction","volume":"122","author":"Wellings","year":"2018","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000551","article-title":"Heart failure following STEMI: a contemporary cohort study of incidence and prognostic factors","volume":"4","author":"Gho","year":"2017","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-8703(97)70168-6","article-title":"Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model","volume":"133","author":"O\u2019Connor","year":"1997","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ahj.2011.08.002","article-title":"Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial","volume":"162","author":"Kelly","year":"2011","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.pcad.2024.01.017_bb0180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction","volume":"139","author":"Arora","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2024.01.017_bb0185","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archinte.158.9.981","article-title":"Observations of the treatment of women in the United States with myocardial infarction: a report from the national registry of myocardial infarction-I","volume":"158","author":"Chandra","year":"1998","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.pcad.2024.01.017_bb0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ejheart.2008.06.004","article-title":"Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention","volume":"10","author":"Santoro","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.pcad.2024.01.017_bb0195","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/eurheartj\/ehr064","article-title":"Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling","volume":"32","author":"Masci","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0200","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.pcad.2024.01.017_bb0205","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0735-1097(02)01737-0","article-title":"Antecedent hypertension and heart failure after myocardial infarction","volume":"39","author":"Richards","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.pcad.2024.01.017_bb0210","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ehj.2004.08.006","article-title":"An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry","volume":"25","author":"Velazquez","year":"2004","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2004.10.054","article-title":"Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction","volume":"45","author":"Prasad","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2024.01.017_bb0220","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.amjcard.2017.03.016","article-title":"Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI study)","volume":"119","author":"Ertelt","year":"2017","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2024.01.017_bb0225","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/ehjqcco\/qcac022","article-title":"Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016","volume":"9","author":"Kamil","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-001004","article-title":"Peripheral artery disease and outcomes in patients with acute myocardial infarction","volume":"6","author":"Attar","year":"2019","journal-title":"Open Heart"},{"issue":"9","key":"10.1016\/j.pcad.2024.01.017_bb0240","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(86)80329-1","article-title":"Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival","volume":"7","author":"Simoons","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2024.01.017_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015186","article-title":"Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: a multivariate network meta-analysis","volume":"9","author":"Fazel","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM200008103430602","volume":"343","author":"Sch\u00f6mig","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0265","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0270","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.pcad.2024.01.017_bb0275","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.107.748772","article-title":"Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction","volume":"118","author":"Ishii","year":"2008","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pcad.2024.01.017_bb0280","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE inhibitor myocardial infarction collaborative group","volume":"97","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2024.01.017_bb0285","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"issue":"9215","key":"10.1016\/j.pcad.2024.01.017_bb0290","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.pcad.2024.01.017_bb0295","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9335","key":"10.1016\/j.pcad.2024.01.017_bb0300","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ahj.2005.03.038","article-title":"Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction","volume":"150","author":"Onodera","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0310","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","article-title":"The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the valsartan in acute myocardial infarction trial (VALIANT)","volume":"47","author":"McMurray","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2024.01.017_bb0315","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.pcad.2024.01.017_bb0320","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2024.01.017_bb0325","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10.1016\/j.pcad.2024.01.017_bb0330","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"10.1016\/j.pcad.2024.01.017_bb0335","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized double-blind reminder study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2024.01.017_bb0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"issue":"17","key":"10.1016\/j.pcad.2024.01.017_bb0345","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.101.17.2103","article-title":"Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling","volume":"101","author":"Prabhu","year":"2000","journal-title":"Circulation"},{"issue":"7200","key":"10.1016\/j.pcad.2024.01.017_bb0350","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"issue":"9266","key":"10.1016\/j.pcad.2024.01.017_bb0355","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0360","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"issue":"9497","key":"10.1016\/j.pcad.2024.01.017_bb0365","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1291\/hypres.23.187","article-title":"Direct effects of statins on cells primarily involved in atherosclerosis","volume":"23","author":"Chen","year":"2000","journal-title":"Hypertens Res"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0375","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijcard.2005.05.014","article-title":"Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI","volume":"108","author":"Wright","year":"2006","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2024.01.017_bb0380","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","article-title":"Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study","volume":"47","author":"Scirica","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.pcad.2024.01.017_bb0385","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.pcad.2024.01.017_bb0390","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.pcad.2024.01.017_bb0395","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.122.060841","article-title":"The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial","volume":"146","author":"Mehran","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0400","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1002\/ehf2.13677","article-title":"The benefits of sacubitril-valsartan in patients with acute myocardial infarction: a systematic review and meta-analysis","volume":"8","author":"Xiong","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.pcad.2024.01.017_bb0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","article-title":"SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart","volume":"4","author":"Lim","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"20","key":"10.1016\/j.pcad.2024.01.017_bb0410","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2022.03.353","article-title":"Sodium glucose cotransporter-2 inhibition for acute myocardial infarction: JACC review topic of the week","volume":"79","author":"Udell","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10166","key":"10.1016\/j.pcad.2024.01.017_bb0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"41","key":"10.1016\/j.pcad.2024.01.017_bb0420","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","volume":"43","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.pcad.2024.01.017_bb0425","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.119.039996","article-title":"Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction","volume":"139","author":"Furtado","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.01.017_bb0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2022.05.010","article-title":"Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial","volume":"253","author":"Harrington","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2024.01.017_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2023.08.008","article-title":"Rationale and design of the DAPA-MI trial: dapagliflozin in patients without diabetes mellitus with acute myocardial infarction","author":"James","year":"2023","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.pcad.2024.01.017_bb0440","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacbts.2021.07.011","article-title":"Update on cardioprotective strategies for STEMI: focus on supersaturated oxygen delivery","volume":"6","author":"Kloner","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/j.pcad.2024.01.017_bb0445","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2217\/fca-2020-0133","article-title":"Novel intracoronary supersaturated oxygen treatment for anterior myocardial infarction","volume":"17","author":"Wheeler","year":"2021","journal-title":"Future Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0450","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/jcm11061509","article-title":"Intracoronary application of super-saturated oxygen to reduce infarct size following myocardial infarction","volume":"11","author":"Sch\u00e4fer","year":"2022","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.pcad.2024.01.017_bb0455","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0460","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.pcad.2024.01.017_bb0465","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0470","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcin.2015.10.039","article-title":"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI registry","volume":"9","author":"Wayangankar","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2024.01.017_bb0475","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9149(80)90067-3","article-title":"Percutaneous intraaortic balloon insertion","volume":"46","author":"Bregman","year":"1980","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1016\/j.pcad.2024.01.017_bb0480","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pcad.2024.01.017_bb0485","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2011.1280","article-title":"Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial","volume":"306","author":"Patel","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pcad.2024.01.017_bb0490","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pcad.2024.01.017_bb0495","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.pcad.2024.01.017_bb0500","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2022.08.807","article-title":"Randomized trials of percutaneous microaxial flow pump devices: JACC state-of-the-art review","volume":"80","author":"Pahuja","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.01.017_bb0505","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ahj.2022.08.011","article-title":"Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: rationale and design of the STEMI-DTU randomized pivotal trial","volume":"254","author":"Kapur","year":"2022","journal-title":"Am Heart J"},{"issue":"18","key":"10.1016\/j.pcad.2024.01.017_bb0510","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2019.02.044","article-title":"Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction","volume":"73","author":"Brunner","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2024.01.017_bb0515","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00392-020-01778-8","article-title":"Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-shock study","volume":"110","author":"Lackermair","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2024.01.017_bb0520","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4244\/EIJ-D-23-00204","article-title":"Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial","volume":"19","author":"Singh","year":"2023","journal-title":"EuroIntervention"},{"issue":"14","key":"10.1016\/j.pcad.2024.01.017_bb0525","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:22:29Z","timestamp":1758500549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062024000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":105,"alternative-id":["S0033062024000173"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2024.01.017","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of post-myocardial infarction care: From acute ischemia to heart failure","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2024.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}